PACIFICSOURCE COMMUNITY SOLUTIONS AND GORGE COORDINATED CARE ORGANIZATION. Chronic Pain and Opiate Management Initiatives

Similar documents
Best Practices in Prescribing Opioids for Chronic Non-cancer Pain

MANAGING PAIN WHILE MINIMIZING RISK OF SUBSTANCE USE DISORDER OUTLINE. EPIDEMIC / CRISIS The Epidemic / Crisis Around Opioid Prescription Use

Montgomery County Poisoning Death Review, 2016: Quarter I Updated June 20, 2016

BC Coroners Service Prescription Opiate-Related Overdose Deaths

Pain Management Wrap-Up Chronic Care. David Tauben, MD Medicine Anesthesia & Pain Medicine

Department of Veterans Affairs Network Policy No.: VA Desert Pacific Healthcare Network (VISN 22) Date: September 23, 2014 Long Beach, CA

Opiate Use among Ohio Medicaid Recipients

OPIOID PRESCRIBING RULES. May 17, 2017 Webinar

Does ultram show up as an opiate

April 26, New Mexico Board of Pharmacy Prescription Monitoring Program (PMP) New Mexico Board of Pharmacy Prescription Monitoring Program (PMP)

ARKANSAS DEPARTMENT OF HEALTH

15 mg morphine 10 mg hydrocodone

Subject: Pain Management (Page 1 of 7)

Opioid Management of Chronic (Non- Cancer) Pain

Opioid Addiction Statistics

Chronic Pain Management in the Primary Care Setting

Opioid Stewardship Davies Presentation

Oregon Prescription Drug Monitoring Program

10 mg hydrocodone equals how much oxycodone

Opioids: Use and Misuse/Steven Feinberg, MD; Scott Levy, MD, MPH, FACOEM

PAIN MANAGEMENT DISCHARGE COMMUNICATION (PM-DC) AUDIT TOOL

Identification of Specific Drugs and Drug Diversion in Drug Overdose Fatalities

CHANGING CULTURE, BUILDING A SYSTEM, SUPPORTING PATIENTS AND STAFF. Andrew Suchocki, MD, MPH Medical Director Clackamas Health Centers

Patient Review and Coordination Program

Disclosures. You're in Control or Urine Control Clinical Pearls of Drug Testing Case Studies. 9/20/17

Challenges in Conducting Postmarketing Abuse Investigations

Michael M. Miller, MD, FASAM, FAPA

Oxycontin conversion to ms contin

Spotlight on Health Policy Beyond the Clinical: The Opioid Epidemic. October 25, 2017

Do your Part Be the Solution

Dose equivalent of fentanyl patch to oxycontin

Appendix 1. University of Minnesota Amplatz Children s Hospital Opioid Weaning Guideline

Reducing Opioid Over- Prescribing in a Large Integrated Health Care System

TITLE: Guidelines for Treatment of Chronic Pain EFFECTIVE DATE: LAST REVISED DATE: LAST REVIEWED DATE:

Urine Drug Testing to Monitor Opioid Use In Managing Chronic Pain

Opioid Analgesics. Recommended starting dose for opioid-naïve patients

An Evaluation of the DoD Transdermal Fentanyl Pharmacy Edit. LTC Stacia Spridgen, MSC, USA Director, DoD Pharmacoeconomic Center

Medicines Optimisation Strategy

See Important Reminder at the end of this policy for important regulatory and legal information.

Oregon s PDMP: An epidemiological assist tool

Ranked in the top 10% in: -Low percent of adults reporting fair or poor health

Managing Narcotics on Workers Comp Claims. Presented By: Craig S. Stern, PharmD, MBA President Pro Pharma Pharmaceutical Consultants, Inc.

Michigan Automated Prescription System

Implementing Pain and Opioid Management Guidelines in Primary Care Practice

HOPE. Considerations. Considerations ISING. Safe Opioid Prescribing Guidelines for ACUTE Non-Malignant Pain

FENTANYL CITRATE TRANSMUCOSAL UTILIZATION MANAGEMENT CRITERIA

See Important Reminder at the end of this policy for important regulatory and legal information.

Convert hydrocodone to ms contin

Bree Collaborative AMDG Opioid Prescribing Guidelines Workgroup. Opioid Prescribing Metrics - DRAFT

Rule Governing the Prescribing of Opioids for Pain

Conversion chart from fentanyl to opana er

CONCERNED ABOUT TAKING OPIOIDS AFTER SURGERY?

NBPDP Drug Utilization Review Process Update

Top 10 narcotic pain pills

Practical Tools to Successfully Taper Prescription Opioids. Melissa Weimer, DO, MCR

CHSP, CPSO RN, BSN, JD,

ONTARIO S STRATEGY TO PREVENT OPIOID ADDICTION AND OVERDOSE. Dr. David Williams Chief Medical Officer of Health

URINE DRUG TOXICOLOGY

Changing Course: statewide efforts to combat the opioid epidemic in California

Use of Opioids for Chronic Non Malignant Pain (CNMP)

Tramadol does it test positive for oxycodone tests positive tests test can positive oxycodone tramadol can Stick dude kil ing arena unblocked test

Policy and Issuance Patient Age Group: ( ) N/A ( ) All Ages ( ) Newborns ( X) Pediatric ( X) Adult

Conflict of Interest Disclosure

PRESCRIBING GUIDELINES

CDC s Efforts to End the Opioid Epidemic

Is percocet stronger than demerol po

Duragesic patch. Duragesic patch (fentanyl patch) Description

Testing for Controlled Substances

The Population is Abusing Drugs, but are Drugs Abusing Insurance?

Opioid epidemic and PEHP

Morphine er to oxycontin conversion

Primary Care Coordination

The Role of Dentists in Preventing Opioid Abuse Tufts Health Care Institute Program on Opioid Risk Management 12 th Summit Meeting March 11-12, 2010

Opioids: What You Should Know About Opioid Prescribing. Denis G. Patterson, DO Nevada State Medical Association October 19, 2016

USE OF OPIODS AT HIGHER DOSES IN PERSONS WITHOUT CANCER: MORPHINE EQUIVALENT DOSE EDIT

UnitedHealthcare Pharmacy Clinical Pharmacy Programs

Welcome - we will begin the webinar shortly Please read the participation tips below:

Interdisciplinary Management of Opioid Use Disorder in Rural Primary Care Settings

How many days does hydrocodone stay in your system

Po dilaudid versus iv dilaudid

Opioid Prescribing Tips & Tricks CANDY STOCKTON, MD MAY 2018

WORRIED ABOUT PAIN AFTER ORAL SURGERY?

Central Oregon Pain Standards Task Force Strategic Initiatives 2015

Aetna s Initiative on the Opioid Epidemic

Interventions in Prescription Opioid Abuse Do (or can) Prescription Monitoring Programs Make a Difference?

Urine Drug Testing In Pain Management and Substance Abuse Treatment Corporate Medical Policy

New Mexico Board of Pharmacy Prescription Monitoring Program (PMP)

TN Opioid Program. Erica Schlesinger, Pharm.D

Chronic Pain Pharmacist role in the clinic

Demerol 50 mg vs hydrocodone

Opioid analgesic therapy in pain management: how we got here from there

PRESCRIPTION DRUG MONITORING PROGRAM

Opioid Epidemic as it Relates to Counties

Public Policy and Best Practices for Reducing Opioid Harm. State Capital Building, Harrisburg PA June 6, 2018

Standard of Practice for Prescribing Opioids (Excluding Cancer, Palliative, and End-of-Life Care)

THA Medication Safety Summit. Wesley Geminn, PharmD, BCPP

A brief history of urine drug testing. Forging a common vocabulary for urine drug testing

Recent Developments in FRA s Post-Accident Toxicological Testing Program

NATL. II. Health Net Approved Indications and Usage Guidelines: Diagnosis of cancer AND. Member is on fentanyl transdermal patches AND

Understanding the STOP Act s 5- and 7-day prescribing limits

Transcription:

PACIFICSOURCE COMMUNITY SOLUTIONS AND GORGE COORDINATED CARE ORGANIZATION Chronic Pain and Opiate Management Initiatives

Objectives To enhance understanding of current concepts, guidelines and risks of chronic opiate therapy. To enhance patient and community safety through promotion of responsible opiate prescribing To review the strategic initiatives which have impacted opiate prescribing practices in Hood and Wasco counties. To reduce prescription and overall health care costs in opiate dependent patients

Interventions Development of Chronic Pain and Opiate Management Strategic Initiatives Stratifying Patient Care Based on Risk: 1. DME > 120mg 2. Opiate Risk Assessment Education campaign 11 presentations to over 190 health care providers (10/14-12/14) Implementation of prescription limits: based on DME of 120mg (12/1/14)

DME Quantity Limits www.agencymeddirectors.wa.gov/guidelines.asp (electronic opiate dose calculator) Drug Equianalgesic dose (oral) Maximum Daily Dose For quant. limitation Morphine 30mg 120mg Hydrocodone 30mg 120mg Oxycodone 20mg 80mg Methadone 10mg 40mg Hydromorphone 7.5mg 30mg Fentanyl 12mcg 50mcg

Stratifying care based on Risk Opioid Risk Tool (www.partnersagainstpain.com/printouts/opioid_risk_tool.pdf) Score Risk <3 Low 3-7 Moderate >8 High Note: the medical evidence for stratifying care plan based on ORT score is poor

Stratifying care based on Risk LOW RISK (ORT SCORE 0-3 OR DME < 40MG) PCP based management for COT refill Provider pain assessment - minimum every 6 months Dose reduction and/or tapering with functional improvement Urine drug screening every 6-12 months

Stratifying care based on Risk Moderate Risk (ORT score 4-7 OR DME 40-120mg) PCP based management for COT refills Referral for addiction assessment prior to or concomitant with Rx for COT Referral for behavioral health assessment prior to or concomitant with Rx for COT Provider pain assessment every 1 to 3 months minimum Reduced Rx intervals (refills sufficient for 1-2 weeks until compliance confirmed then monthly) Urine drug screening every 3-6 months until compliance established, then every 6-12 months

Stratifying care based on Risk HIGH RISK (ORT 8 OR DME > 120MG) PCP shall refer patient to a provider specializing in chronic pain management or a multidisciplinary pain clinic to obtain recommendations for COT Addiction assessment is indicated and addiction treatment (if needed) Behavioral health assessment and treatment is indicated Provider pain assessment every 2-4 weeks until compliance is demonstrated, then every 1-3 months (see X) Reduced Rx intervals (refills sufficient for 1-2 week initially, then every 2-4 weeks) Urine drug screening randomly at least monthly until stable pattern and compliance established then every 3-6 months

Outcome Measures 1. The number of patients receiving chronic opiate therapy 2. The number of patients with DME of 120mg or greater 3. RX cost 4. Overall healthcare cost

Baseline Data: opiate RX repeating > 6 mos 38 patients had membership which lapsed during the data collection period

Baseline Data: adjusted 6 month Of 120 cohort members, 96 members refilled opiate RXs for 6 consecutive months

Preliminary 6 month data Of 120 cohort members, 14 members had no opiate RXs refilled and 67 members had opiate RXs refilled for at 6 consecutive months.

Conclusions: Number of pts receiving COT 14 members who were opiate dependent for at least 6 months during baseline data period have not refilled opiates during the 6 month follow up period Of the 120 cohort members, the percent of patients who have filled opiate RXs for at least 6 consecutive months went down from 80% (96/120) to 63% (67/120), a 21% reduction

Baseline Data Jan-June 2014

Preliminary data: Jan-June 2015

Conclusion: number of patients on DME>120mg The number of patients on high dose opiate RX (DME 120mg or more) went down from 10% (12/120) to 6.6% (7/106). This is a 34% reduction in the number of patients on DME>120mg

Overall Prescription Cost

Overall Health Care Cost

Conclusions: RX and overall costs PMPM RX cost for chronic opiate users was not significantly impacted. PMPM Net Pay was reduced by 34% in chronic opiate users

Summary Implementation of Opiate Management Strategies: - reduced the # of pts on COT - reduced the # of pts on high dose COT - reduced overall healthcare cost Education was a key element to the success of changing the culture associated with opiate prescribing Next Steps stay tuned

Summary Questions and Discussion